# Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)

> **NCT02333851** · PHASE4 · TERMINATED · sponsor: **Hospital Universitario Central de Asturias** · enrollment: 72 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Mixtard 30:70 Novonordisk® twice daily
- **DRUG:** Lantus® once daily and Apidra® before meals

## Key facts

- **NCT ID:** NCT02333851
- **Lead sponsor:** Hospital Universitario Central de Asturias
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 72 (ACTUAL)
- **Why stopped:** Safety reasons
- **Last updated:** 2015-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02333851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02333851, "Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02333851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*